Celgene Corp
Change company Symbol lookup
Select an option...
CELG Celgene Corp
MEI Methode Electronics Inc
JPM JPMorgan Chase & Co
C Citigroup Inc
AMZN Amazon.com Inc
LIN Linde PLC
UTX United Technologies Corp
ITUB Itau Unibanco Holding SA
AEE Ameren Corp
ADM Archer Daniels Midland Co
Go

Health Care : Biotechnology | Large Cap BlendCompany profile

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Closing Price
$99.37
Day's Change
0.42 (0.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
99.66
Day's Low
98.50
Volume
(Heavy Day)
Volume:
5,387,529

10-day average volume:
3,297,201
5,387,529
  • Prev Close
    98.95
  • Today's Open
    98.65
  • Day's Range
    98.50-99.66
  • Avg Vol (10-day)
    3.3M
  • Last (time)
    3:59p ET 09/20/19
  • Last (size)
    100
  • 52-Wk Range
    58.59 - 99.66
    LowHigh
  • (12/26/18 - 09/20/19)
    0.29%
  • 32.7%
  • Market Cap
    70.4B
  • Shares Outstanding
    708.7M
  • 7.25
  • 13.64x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 72.23
  • (% of float 08/30/19)
    1.78

Latest News

September 12, 2019
4:30 pm ET
BusinessWire
September 09, 2019
7:30 am ET
BusinessWire
September 05, 2019
9:00 am ET
PR Newswire
September 04, 2019
7:00 am ET
PR Newswire
September 02, 2019
12:55 pm ET
BusinessWire
August 28, 2019
10:00 am ET
PR Newswire
August 26, 2019
6:51 am ET
MarketWatch
6:32 am ET
MarketWatch
6:30 am ET
BusinessWire
4:26 am ET
PR Newswire
August 21, 2019
8:30 am ET
PR Newswire
August 16, 2019
10:30 am ET
BusinessWire
August 14, 2019
1:26 am ET
Accesswire
August 13, 2019
3:11 pm ET
MarketWatch
August 09, 2019
7:27 am ET
MarketWatch
August 08, 2019
4:07 pm ET
Globe Newswire
August 05, 2019
4:05 pm ET
BusinessWire
July 31, 2019
7:07 am ET
BusinessWire
July 30, 2019
7:55 am ET
MarketWatch
7:30 am ET
BusinessWire
July 29, 2019
10:10 am ET
BusinessWire
July 26, 2019
1:24 pm ET
Globe Newswire
July 25, 2019
6:59 am ET
BusinessWire
July 24, 2019
1:30 pm ET
Globe Newswire
11:19 am ET
Globe Newswire
7:30 am ET
BusinessWire
7:15 am ET
MarketWatch
July 23, 2019
4:00 pm ET
Globe Newswire
July 19, 2019
1:59 pm ET
BusinessWire
July 16, 2019
8:30 am ET
BusinessWire
July 15, 2019
4:01 pm ET
Globe Newswire
July 13, 2019
7:26 am ET
MarketWatch
July 09, 2019
7:00 am ET
BusinessWire
July 02, 2019
4:07 pm ET
PR Newswire
July 01, 2019
1:46 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.